# EtCO2 for Monitoring and Predicting Severity of DKA in Pediatric Emergency, Doha, Qatar.

> **NCT04121572** · — · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 150 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** Nasal cannula capnography

## Key facts

- **NCT ID:** NCT04121572
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-10
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04121572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04121572, "EtCO2 for Monitoring and Predicting Severity of DKA in Pediatric Emergency, Doha, Qatar.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04121572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*